ArticleOpen forum infectious diseases2020
Epidemiology of Vancomycin-Resistant
Article in Open forum infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Comparative genomic characterization and antimicrobial resistance of bacteremia-causingMicrobiology spectrum · 2026Article
- Article
- Methicillin-ResistantMicroorganisms · 2026Review
- Resistance to last-resort antibiotics in enterococci.FEMS microbiology reviews · 2025Review
- Chemical Characterization and Antimicrobial Activity of Green Propolis from the Brazilian Caatinga Biome.Plants (Basel, Switzerland) · 2024Article
- Prevalence of Enterococcus Species in Various Clinical Samples and Their Antimicrobial Susceptibility Pattern.Cureus · 2024Article
- Linezolid-resistant Enterococcus faecium clinical isolates from Pakistan: a genomic analysis.BMC microbiology · 2024Article
- Vancomycin Resistance inMicroorganisms · 2022Review
- Occurrence of bacteria belonging to the genus Enterococcus and Staphylococcus on inanimate surfaces of selected hospital facilities and their nosocomial significance.Central European journal of public health · 2022Article
- Long-Term Safety Following Faecal Microbiota Transplantation as a Treatment for RecurrentCells · 2022Review
- Meeting the Unmet Need in the Management of MDR Gram-Positive Infections with Oral Bactericidal Agent Levonadifloxacin.Critical care research and practice · 2022Review
- Let Me Upgrade You: Impact of Mobile Genetic Elements on Enterococcal Adaptation and Evolution.Journal of bacteriology · 2021Review
- Characterization of the Gut Microbiome and Resistomes of Wild and Zoo-Captive Macaques.Frontiers in veterinary science · 2021Article
- Development and Characterization of High-ThroughputFrontiers in cellular and infection microbiology · 2021Article
- Vancomycin-Resistant Enterococci (VRE) in Nigeria: The First Systematic Review and Meta-Analysis.Antibiotics (Basel, Switzerland) · 2020Review
- Factors affecting vancomycin-resistantTzu chi medical journalArticle
- A systematic review and meta-analysis on the prevalence of vancomycin-resistant enterococci (VRE) among Nigerians.Porto biomedical journalReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundVancomycin-resistant
methodsWe enrolled 651 newly admitted patients from 6 different NFs and collected swabs from several body sites at enrollment, 14 days, 30 days, and monthly thereafter for up to 6 months. The VRE were speciated using a duplex polymerase chain reaction. We used multinomial logistic regression models to compare risk factors associated with colonization of
resultsOverall, 40.7% were colonized with
conclusionsRecent increases in vancomycin-resistant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.